Trial Profile
Efficacy trial of ingestion of the developmental code USRP-003
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Sep 2019
Price :
$35
*
At a glance
- Drugs USRP 003 (Primary)
- Indications Nocturia
- Focus Therapeutic Use
- Sponsors Kao Corporation
- 30 Aug 2019 Status changed from not yet recruiting to completed.
- 07 Sep 2018 New trial record